January 23, 2021

Volume XI, Number 23

Advertisement

January 22, 2021

Subscribe to Latest Legal News and Analysis

January 21, 2021

Subscribe to Latest Legal News and Analysis

January 20, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
8
Jul
Colorado Supreme Court: Medical Use of Marijuana Not ‘Lawful’ Jackson Lewis P.C.
7
Jul
The Compounding Regulations Surrounding Drug Compounding McBrayer, McGinnis, Leslie and Kirkland, PLLC
2
Jul
FDA Releases Draft Guidance on its Voluntary Qualified Importer Program Faegre Drinker
2
Jul
Second Circuit Appellate Court Weighs In on Pharmaceutical “Product Hopping” McDermott Will & Emery
1
Jul
Activities For sNDA and Citizen’s Petition Protected by “Safe Harbor” - Supplemental New Drug Application McDermott Will & Emery
1
Jul
No Induced Infringement Where Off-Label Use of a Drug Is Not “Inevitable” McDermott Will & Emery
1
Jul
American Simmental Assoc. v. Leachman Cattle of Colorado: Stay of Pending Reissue Application to Avoid Inconsistencies with Post Grant Review PGR2015-00005 Faegre Drinker
1
Jul
FDA Announces Delay in Enforcing DSCSA Requirements for Dispensers McDermott Will & Emery
30
Jun
FDA Provides 11th Hour Delay of Product Tracing Requirements for Pharmacies Mintz
30
Jun
AstraZeneca’s Crestor® Patent is Invalidated by the Brazilian Federal Courts Michael Best & Friedrich LLP
30
Jun
Teva Pharm v. ViiV Healthcare Co: Denying Joinder Where Agreement to File Consolidated Papers Was Not Obtained IPR2015-00550 Faegre Drinker
30
Jun
Federal Circuit Invalidates Another Diagnostic Patent Foley & Lardner LLP
30
Jun
American Simmental Association v. Leachman Cattle of Colorado, LLC: Decision on Institution of Post-Grant Review Faegre Drinker
30
Jun
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
29
Jun
New FMLA Certification Forms Include GINA Safe Harbor Notice Holland & Hart LLP
29
Jun
Jury Hits Employer With $2.2 Million Verdict For GINA Violations in Workplace Defecator Case Mintz
29
Jun
Rocky Mountain High Part II: Colorado’s Highest Court Approves Employer’s Stance that Employee Toke is No Joke Mintz
26
Jun
Amendment to Pennsylvania Liquor Code Allowing Direct Shipment of Wine Stark & Stark
26
Jun
FDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies Mintz
25
Jun
Federal Circuit Strikes Final Blow To Celebrex Patent Foley & Lardner LLP

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement